Pharmacogenomic Testing for SSRIs: How CYP2C19 and CYP2D6 Affect Side Effects
Pharmacogenomic testing for CYP2C19 and CYP2D6 genes helps predict how your body metabolizes SSRIs, reducing side effects and avoiding trial-and-error prescribing. Learn how your genes impact antidepressant tolerance and effectiveness.